Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma

Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma

We present a rare case of a 17-month-old child diagnosed with MS-stage neuroblastoma and associated chronic diarrhea due to elevated vasoactive intestinal peptide (VIP) levels. The unusual occurrence of a VIP-secreting tumor in a patient with MS neuroblastoma is a rare combination, not previously re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Josy Thomas, Nitin James Peters, Aravind Sekar, Deepak Bansal, Jitender Singh, Ravi P. Kanojia, J. K. Mahajan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-11-01
Series:	Journal of Indian Association of Pediatric Surgeons
Subjects:	chronic diarrhea ms neuroblastoma vasoactive intestinal peptide vipoma
Online Access:	https://journals.lww.com/10.4103/jiaps.jiaps_104_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients
by: Juana Benedí-González, et al.
Published: (2018-03-01)

Vasoactive intestinal peptide modulates steroid hormone secretion via the superior ovarian nerve in a rat model of polycystic ovary syndrome
by: Gabriela Rosas Gavilán, et al.
Published: (2024-09-01)

Lower Levels of Vitamin D Are Associated with Higher Vasoactive–Inotropic Scores in Major Cardiac Surgery
by: Adrian Stef, et al.
Published: (2024-10-01)

The Clinical Characteristics of Children with Neuroblastoma
by: Betül Sevinir, et al.
Published: (2013-04-01)

Cell state plasticity in neuroblastoma
by: Adam D. Durbin, et al.
Published: (2024-12-01)

Diagnosis of Multiple Organ Dysfunction in Neonates with Hypoxic–Ischemic Encephalopathy: Vasoactive Inotropic Score, Renal Score, Fibrosis-5 Index and Lactate/Albumin Ratio
by: Başak Kaya, et al.
Published: (2024-12-01)

Spontaneous Intrathoracic Rupture of Abdominal Neuroblastoma in a 2-year-old Child: A Rare Case Report
by: Simmi K. Ratan, et al.
Published: (2024-11-01)

Nasal neuroblastoma: review and case report
by: V. A. Kashirin, et al.
Published: (2020-09-01)

Adult-onset Renal Neuroblastoma: Case Report and Literature Review
by: Yao-Ren Yang, et al.
Published: (2024-12-01)

Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients
by: Emre LEVENTOGLU, et al.
Published: (2023-06-01)

GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01)

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01)

Deep learning for stage prediction in neuroblastoma using gene expression data
by: Aron Park, et al.
Published: (2019-09-01)

Identification of Contactin-1 as a Potential Biomarker and Therapeutic Target in Neuroblastoma
by: Christa N. Grant, et al.
Published: (2024-11-01)

Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study
by: Karina Viani, et al.
Published: (2024-12-01)

Outcome of radiotherapy for metastatic neuroblastoma
by: Noor Muhammed Abdulrahaman, et al.
Published: (2024-09-01)

The case of Kinsburn’s Encephalopathy in a child with neuroblastoma of posterior mediastinum
by: T.I. Stetsenko, et al.
Published: (2024-02-01)

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
by: Seema Chugh, et al.
Published: (2025-02-01)

Presentation of disseminated neuroblastoma mimicking Bell’s palsy: a case report
by: Shamaali Gunawardana, et al.
Published: (2025-01-01)

Proximity Proteomics Reveals USP44 Forms a Complex with BRCA2 in Neuroblastoma Cells and Is Required to Prevent Chromosome Breakage
by: Asma Ali, et al.
Published: (2024-12-01)

The Effectiveness of Computed Tomography Texture Analysis in Distinguishing Wilms Tumor from Neuroblastoma
by: Abdi Gürhan, et al.
Published: (2024-12-01)

Quinic Acid Protects Human SH-SY5Y Neuroblastoma Cells Against Amyloid-β Cytotoxicity
by: Betul Cicek, et al.
Published: (2024-12-01)

The Race Against Time for the Enhancement of African National Strategic Plans in the Neuroblastoma Research Heterogeneity
by: Mmei Cheryl Motshudi, et al.
Published: (2024-12-01)

Exploring parent treatment decision-making in relapsed and refractory neuroblastoma: A qualitative study
by: Helen Pearson, et al.
Published: (2024-12-01)

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
by: Yaya Chu, et al.
Published: (2025-03-01)

DNA repair and replicative stress addiction in neuroblastoma
by: Kaat Durinck, et al.
Published: (2024-12-01)

Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastoma
by: Xingyu Liu, et al.
Published: (2024-11-01)

MYCN in neuroblastoma: The kings' new clothes and drugs
by: Mareike Müller, et al.
Published: (2024-12-01)

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy
by: Turgut Bora Cengiz, et al.
Published: (2025-01-01)

Ectopic primary olfactory neuroblastoma: Clinical management of an extremely rare entity
by: Milena Fior, et al.
Published: (2024-12-01)

Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
by: Jian Cheng, et al.
Published: (2025-01-01)

The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
by: Adeiye A. Pilgrim, et al.
Published: (2023-12-01)

Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single-institution experience and review of the literature
by: Anselm Chi-Wai Lee, et al.
Published: (2023-05-01)

An evaluation of genetic predisposition to congenital anomalies and pediatric cancer supports KAT6B as a novel neuroblastoma susceptibility gene
by: Hyunjung Gu, et al.
Published: (2025-01-01)

Global, regional, and national epidemiology of childhood neuroblastoma (1990–2021): a statistical analysis of incidence, mortality, and DALYsResearch in context
by: Jusen Nong, et al.
Published: (2025-01-01)

Comparison of Bone Marrow Biopsy and Flow Cytometry in Demonstrating Bone Marrow Metastasis of Neuroblastoma
by: Esra Arslantaş, et al.
Published: (2024-12-01)

Personalized circulating tumor DNA analysis for sensitive disease monitoring and detection of relapse in neuroblastoma
by: Ida Rahmqvist, et al.
Published: (2024-11-01)

Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021
by: Chaoyan Yue, et al.
Published: (2025-02-01)

Exploring the Role of Fibroblasts in Promoting Neuroblastoma Cell Migration and Invasion
by: Diana Corallo, et al.
Published: (2024-12-01)

RETRACTED: Targeting MYCN IRES in MYCN‐amplified neuroblastoma with miR‐375 inhibits tumor growth and sensitizes tumor cells to radiation
by: Hailong Zhang, et al.
Published: (2015-08-01)